DANIELLE PETERSON: Open Payments
NPI 1285314450 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$389 in 19 payments from 9 companies in 2025. Trend: 2023 $23 · 2024 $486 · 2025 $389
Food & beverage: $389
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 7 | $150 |
| Sage Therapeutics, LLC | 4 | $87 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $30 |
| SHIELD THERAPEUTICS INC | 1 | $27 |
| Novo Nordisk Inc | 1 | $25 |
| Amgen Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| MILLICENT US INC | 1 | $13 |
Products named: Veozah, ZURZUVAE, ACCRUFER, EVENITY, MOUNJARO, Mirena, INTRAROSA.
Industry payments across MD — which companies pay providers there.
